Parametrica Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$688K	Hold	195,878	–	–	0.78%	17
2025 Q4	$535K	Hold	195,878	–	–	0.82%	18
2025 Q3	$425K	Hold	195,878	–	–	0.66%	21
2025 Q2	$337K	Hold	195,878	–	–	0.63%	20
2025 Q1	$652K	Sell	195,878 -65,212	-25%	-$336K	1.1%	17
2024 Q4	$1.93M	Hold	261,090	–	–	2.55%	11
2024 Q3	$2.45M	Hold	261,090	–	–	2.92%	10
2024 Q2	$2.09M	Buy	261,090 +129,500	+98%	+$1.39M	2.77%	14
2024 Q1	$1.95M	Sell	131,590 -188,686	-59%	-$2.2M	2.81%	12
2023 Q4	$2.6M	Buy	320,276 +224,876	+236%	+$1.18M	4.27%	6
2023 Q3	$434K	Sell	95,400 -1,100	-1%	-$7.18K	0.73%	27
2023 Q2	$679K	Buy	96,500 +47,800	+98%	+$342K	1.31%	22
2023 Q1	$298K	Buy	48,700 +800	+2%	+$5.52K	0.54%	21
2022 Q4	$306K	Sell	47,900 -46,750	-49%	-$365K	0.63%	29
2022 Q3	$907K	Sell	94,650 -21,220	-18%	-$245K	1.85%	13
2022 Q2	$1.27M	Sell	115,870 -18,809	-14%	-$246K	1.38%	19
2022 Q1	$2.24M	Sell	134,679 -14,502	-10%	-$224K	1.66%	12
2021 Q4	$2.85M	Buy	149,181 +2,819	+2%	+$62.1K	2.83%	12
2021 Q3	$3.61M	Buy	146,362 +72,087	+97%	+$1.7M	2.7%	11
2021 Q2	$1.93M	Buy	+74,275	New	+$1.93M	1.43%	25
2020 Q3	–	Sell	-8,754	Closed	-$240K	–	120
2020 Q2	$240K	Buy	+8,754	New	+$288K	0.26%	93